Evaluation of a Hospital-based Hypertension Screening Program in Seven Hospitals in Thailand

Authors

  • Rawinan Soma Division of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand
  • Hirunwat Praekunatham Division of Occupational and Environmental Disease, Department of Disease Control, Ministry of Public Health, Thailand
  • Phanthanee Thitichai Division of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand

DOI:

https://doi.org/10.59096/osir.v16i3.263774

Keywords:

hospital-based screening, hypertension screening, hypertension diagnosis, program evaluation

Abstract

The Department of Disease Control in Thailand piloted an intervention program at seven hospitals around the country for screening hypertension during May–September 2019. The intervention focused on implementing a guideline for managing patients with raised blood pressure. The guideline included provision of a blood pressure notification and follow-up book and conducting meetings to communicate them to the hospital representative, aim for enhancing patient coverage and reducing the risks from persistent hypertension. An evaluation was conducted to assess the effectiveness of the program and identify weaknesses. The evaluation consisted of quantitative and qualitative methods. A comparison of the proportion of newly diagnosed hypertensive patients among patients who had raised blood pressure before and after implementation of the intervention was performed. Healthcare workers in each hospital were interviewed about the work process of the program. The overall proportion of newly diagnosed hypertensive patients increased by 1.1% after the intervention (range: -11.7 to 2.9%). The practice compared between pre- and post-intervention did not have difference as expected. From the qualitative interviews, healthcare workers believed that the decision to make a follow-up appointment rested solely with the physician. Physicians tended to make appointments at one month because of their high workload. Adequate orientation of the guideline and providing robust and feasible processes were essential for the program’s success. Monitoring and evaluation should be done periodically to ensure protocol adherence.

References

World Health Organization. Hypertension: overview [Internet]. Geneva: World Health Organization; [cited 2022 May 16]. <https://www.who.int/health-topics/hypertension#tab=tab_1>

World Health Organization. High blood pressure-measure accurately, control it and live longer [Internet]. Geneva: World Health Organization; 2022 May 16 [cited 2022 Sep 15]. <https://www.who.int/srilanka/news/detail/16-05-2022-high-blood-pressure---measure-accurately--control-it-and-live-longer>

World Health Organization. Cardiovascular diseases (CVDs) [Internet]. Geneva: World Health Organization; 2021 Jun 11 [cited 2022 Sep 15]. <https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)>

Chow CK. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959. doi:10.1001/jama.2013.184182.

Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: national health and nutrition examination survey, 2011–2012. NCHS data brief. 2013 Oct;133:1–8.

Islam FMA, Bhuiyan A, Chakrabarti R, Rahman MA, Kanagasingam Y, Hiller JE. Undiagnosed hypertension in a rural district in Bangladesh: The Bangladesh population-based diabetes and Eye Study (BPDES). J Hum Hypertens. 2016 Apr;30(4):252–9. doi:10.1038/jhh.2015.65.

Najafipour H, Nasri HR, Rostamzadeh F, Amirzadeh R, Shadkam M, Mirzazadeh A. Prevalence and incidence of pre-hypertension and hypertension (awareness/control) in Iran: Findings from Kerman Coronary Artery Diseases Risk Factors Study 2 (KERCADRS). J Hum Hypertens. 2020 May;36(5):461–72. doi:10.1038/s41371-020-00392-5.

Huguet N, Larson A, Angier H, Marino M, Green BB, Moreno L, et al. Rates of undiagnosed hypertension and diagnosed hypertension without anti-hypertensive medication following the Affordable Care Act. Am J Hypertens. 2021 Sep 22;34(9):989–98. doi:10.1093/ajh/hpab069.

Aekplakorn W, editor. 5th Thai national health examination survey. Nonthaburi: Health System Research Institute; 2016 Nov 1. 283 p. Thai.

Health data center database [Internet]. Nonthaburi: Ministry of Public Health; 2018 [cited 2022 May 16]. <https://hdcservice.moph.go.th/hdc/main/index.php>. Thai.

Yueayai, K, Moran, AE, Pratipanwat, P, Chaisongkram, S, Anosri, L, Thitichai, P. Hospital-based intervention to enhance hypertension diagnosis in hospital K, Thailand, 2017-2019: A pre-post pilot intervention study. J Clin Hypertens. 2020 Aug;22(8):1310–20. doi:10.1111/jch.13953.

Guideline for raised blood pressure visitor management for healthcare personnel. Nonthaburi: Division of Non-communicable diseases, Department of Disease Control; 2019. 12 p. Thai.

World Health Organization. (‎2004)‎. ICD-10: international statistical classification of diseases and related health problems: tenth revision, 2nd ed. Geneva: World Health Organization; 2004.

Thai Hypertension Society. 2019 Thai guidelines on the treatment of hypertension [Internet]. Bangkok: Thai Hypertension Society; 2022 Apr [cited 2022 May 16]. 78 p. <http://www.thaihypertension.org/files/HT%20guideline%202019.with%20watermark.pdf>. Thai.

Meador M, Osheroff JA, Reisler B. Improving identification and diagnosis of hypertensive patients hiding in plain sight (HIPS) in health centers. Jt Comm J Qual Patient Saf. 2018 Mar;44(3):117–29. doi:10.1016/j.jcjq.2017.09.003.

Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: Benefits, risks, and strategies for success. NPJ Dig Med. 2020;3(1):17. doi:10.1038/s41746-020-0221-y.

Atasoy S, Middeke M, Johar H, Peters A, Heier M, Ladwig KH. Cardiovascular mortality risk in young adults with isolated systolic hypertension: findings from population-based Monica/Kora cohort study. J Hum Hypertens. 2021 Dec;36(12):1059–65. doi:10.1038/s41371-021-00619-z.

Yano Y, Stamler J, Garside DB, Daviglus ML, Franklin SS, Carnethon MR, et al. Isolated systolic hypertension in young and middle-aged adults and 31-year risk for cardiovascular mortality. J Am Coll Cardiol. 2015;65(4):327–35. doi:10.1016/j.jacc.2014.10.060.

Peng X, Jin C, Song Q, Wu S, Cai J. Stage 1 hypertension and the 10-year and lifetime risk of cardiovascular disease: A prospective real-world study. J Am Heart Assoc. 2023 Apr 4;12(7):e028762. doi:10.1161/jaha.122.028762.

Antikainen R, Jousilahti P, Tuomilehto J. Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population. J Hypertens. 1998 May;16(5):577–83. doi:10.1097/00004872-199816050-00004.

Published

2023-09-28

How to Cite

Soma, R., Praekunatham, H., & Thitichai, P. (2023). Evaluation of a Hospital-based Hypertension Screening Program in Seven Hospitals in Thailand. Outbreak, Surveillance, Investigation & Response (OSIR) Journal, 16(3), 153–160. https://doi.org/10.59096/osir.v16i3.263774

Issue

Section

Original article